Wendelsheim, Germany (ots/PRNewswire) – Key messages
- Thermo Fisher Scientific has been named the exclusive distributor of FDA-approved Aesku products in the United States.
- Thermo Fisher Scientific is a leading provider of instruments and consumables for the specialty diagnostics market, whose portfolio of immunodiagnostics products is now complemented by Aesku.
- The five-year contract also includes service and support tasks.
The agreement between Thermo Fisher Scientific and Aesku provides customers with access to a comprehensive portfolio of autoimmune diagnostics and automated instruments, including both the EliA™ autoimmune testing portfolio and Phadia™ laboratory equipment with Aesku’s IFA tests and Helios® HTC systems add to.
Thermo Fisher Scientific – the world’s leading company serving science – today entered into an exclusive distribution agreement with Aesku.Group (Aesku) – a leading provider of innovative diagnostic solutions – to market, sell and support its portfolio of FDA-approved IFAs products, automated devices and software in the United States. With this agreement, Thermo Fisher offers a comprehensive range of automated diagnostic systems and methods for the US market.
By expanding its immunology product portfolio – consisting of EliA autoimmune diagnostics, ImmunoCAP™ allergy diagnostics and Phadia laboratory systems with complementary reagents and systems from Aesku – Thermo Fisher will continue to meet the evolving needs of laboratories and healthcare professionals and enable faster and more accurate diagnoses for patients .
“Our partnership with Aesku underscores our commitment to empowering our customers to make the world healthier by providing innovative solutions that advance the detection and diagnosis of complex autoimmune diseases,” said Santhosh Nair, President, ImmunoDiagnostics, Thermo Fisher Scientific “Aesku has developed innovative and efficient solutions that fit seamlessly into our existing product portfolio. We are pleased to be able to offer these solutions to our customers and have the opportunity to positively impact more patient lives.”
Under the terms of the agreement, Thermo Fisher will handle sales, marketing and related activities for Aesku products exclusively in the United States. Thermo Fisher will also provide installation, maintenance and support services to customers in the United States. Aesku remains the manufacturer for all products under the agreement.
Dr. Torsten Matthias, Managing Director and Founder of Aesku, said about the cooperation: “We are very pleased to partner with Thermo Fisher Scientific, a world-leading diagnostics company, to bring our groundbreaking IFA solutions to the US market. Aesku’s commitment to innovation in autoimmune diagnostics aligns seamlessly with Thermo Fisher’s mission to enable customers to make the world healthier, cleaner and safer. Together, we are setting new standards for the accuracy and efficiency of autoimmunity testing, ensuring clinics and patients have the most advanced diagnostic options available.”
For more information about Thermo Fisher Scientific’s immunology solutions, visit https://www.thermofisher.com/phadia
About Thermo Fisher Scientific
Thermo Fisher Scientific Inc. is the world’s leading science company with annual revenues exceeding $40 billion. The company’s mission is to help its customers make the world healthier, cleaner and safer. Whether customers are advancing life sciences research, solving complex analytical challenges, increasing productivity in their laboratories, improving patient health through diagnostics, or developing and manufacturing life-changing therapies, we are here to support them. Our global team delivers an unmatched combination of innovative technologies, streamlined purchasing processes and pharmaceutical services through our industry-leading brands Thermo Scientific, Applied Biosystems, Invitrogen, Fisher Scientific, Unity Lab Services, Patheon and PPD. Further information at www.thermofisher.com
About the Aesku.Group
The Aesku.Group, based in Wendelsheim/Rhineland-Palatinate, is a research-oriented provider of innovative and efficient products and services for the early detection, diagnosis and prognosis of autoimmune diseases. Since its founding in 2000, Aesku.Diagnostics has become a recognized name in the autoimmunity field with the launch of over 150 different products and ongoing services in more than 90 countries worldwide. Since then, Aesku.Group has simplified laboratory routines with precise, robust and reliable tests and has earned a solid reputation in autoimmune diagnostics, with equal attention to all major disease areas. Further information at www.aesku.com
Photo – https://mma.prnewswire.com/media/2300098/Aseku_Group_1.jpg
Logo – https://mma.prnewswire.com/media/2300100/Aseku_Group_Logo.jpg
View original content to download multimedia:https://www.prnewswire.com/de/pressemitteilungen/thermo-fisher-scientific-unterzeichnet-langfristigen-exklusiven-us-vertriebsvertrag-mit-aeskugroup-fur-ifa-testkits-und–instrumente-302014247.html
Questions & Contact:
Janka Kreisl,
+49 (0)172 7593078,
j.kreissl@dunkelblau.com